Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

New U.S. patent covers use of anti-CTGF antibodies to treat fibrotic disorders

Oct. 19, 1998

First FDA approval for once-daily use of an inhaled corticosteroid for asthma

Oct. 16, 1998

Collaborative agreements in the field of asthma signed by SkyePharma and Sepracor

Oct. 15, 1998

Trega concludes phase I testing of HP-228 inhalation formulation

Oct. 13, 1998

Neutrophil inhibitor peptides available for licensing from RCT

Oct. 13, 1998

FDA continues to support development of SciClone's CF Rx

Oct. 9, 1998

HMR announces Spanish launch of Telfast

Oct. 9, 1998

Anti-IgE antibody in the treatment of asthma: an interesting theory is validated

Oct. 8, 1998

Genotyping accurately predicts response to treatment with 5-LO inhibitor

Oct. 8, 1998

PAF antagonists in the treatment of asthma: promise or hype?

Oct. 8, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...